D
Dianthus Therapeutics, Inc. (DNTH)
NCM – Real Time Price. Currency in USD
86.15
-0.97 (-1.11%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
86.15
-0.97 (-1.11%)
At close: May 12, 2026, 4:00 PM EDT
Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases. Its lead clinical-stage candidate, claseprubart, a monoclonal antibody engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein; and DNTH212, a bifunctional fusion protein that targets plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B cell function. Dianthus Therapeutics, Inc. was founded in 2019 and is headquartered in New York, New York.
| Name | Position |
|---|---|
| Dr. Simrat Randhawa M.B.A., M.D. | Executive VP and Head of R&D |
| Mr. Adam M. Veness Esq. | Senior VP, General Counsel & Secretary |
| Mr. Edward G. Carr | Senior VP & Chief Accounting Officer |
| Mr. Judson Taylor | Senior VP & Head of Technical Operations |
| Mr. Marino Garcia M.B.A. | President, CEO & Director |
| Mr. Ryan Savitz | Executive VP, CFO, Chief Business Officer & Treasurer |
| Mr. Scott Nogi M.B.A. | Head of Business Operations |
| Ms. Jennifer Davis Ruff | VP and Head of Investor Relations & Corporate Affairs |
| Ms. Kristina Maximenko | Chief People Officer |
| Ms. Rashieda Gluck | Head of Clinical Development Operations |
| Date | Type | Document |
|---|---|---|
| 2026-05-05 | 8-K | dnth-20260505.htm |
| 2026-04-09 | DEF 14A | dnth-20260409.htm |
| 2026-03-26 | 8-K | dnth-20260326.htm |
| 2026-03-12 | 8-K | d43448d8k.htm |
| 2026-03-10 | S-3MEF | d115984ds3mef.htm |
| 2026-03-09 | 10-K | dnth-20251231.htm |
| 2026-01-29 | CORRESP | filename1.htm |
| 2026-01-28 | S-3 | d53438ds3.htm |
| 2026-01-12 | 8-K | dnth-20260112.htm |
| 2025-11-05 | 8-K | dnth-20251105.htm |